PGC-1α-modulating peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9266921
APP PUB NO 20140086981A1
SERIAL NO

14006981

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Peptides of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases which improve or are prevented by PGC-1α modulation.

description='In-line Formulae' end='lead'R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2  (I)description='In-line Formulae' end='tail'

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LIPOTEC S AE-08550 GAVA (BARCELONA)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Almiñana, Domenech Nuria Barcelona, ES 8 115
Ferrer, Montiel Antonio Vicente Alicante, ES 19 167
García, Antón José María Barcelona, ES 7 86

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00